» Articles » PMID: 10073600

Prominence of Cell-mediated Immunity Effectors in "pauci-immune" Glomerulonephritis

Overview
Specialty Nephrology
Date 1999 Mar 12
PMID 10073600
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The majority of patients with rapidly progressive crescentic glomerulonephritis show histologic features of extensive necrosis and focal and segmental proliferation with fibrin production, but little or absent Ig deposition in the glomerulus. This subcategory of the disease, labeled "pauci-immune" glomerulonephritis, has recently been shown to be associated with the presence of antineutrophil cytoplasmic antibody in the patient's circulation (but not within the glomerulus). The absence of the effectors of humoral immunity at the site of renal injury led to this investigation of the contribution of cell-mediated immunity to the glomerular injury in this form of glomerulonephritis. In 15 patients presenting acutely with pauci-immune glomerulonephritis, CD3-positive T cells (3.7+/-2.5 [mean +/- SD] cells per glomerular cross section, [c/gcs]), CD45RO-positive T cells (2.7+/-1.9 c/cgs), macrophages (7.3+/-6.1 c/gcs), fibrin (3+), and endothelial-associated tissue factor were demonstrated to be prominent in glomeruli. These mediators were absent in a group of 12 patients with thin basement membrane disease and only occasionally observed in a group of eight patients with "humorally mediated"(noncrescentic) glomerulonephritis. Thus, in pauci-immune glomerulonephritis, there is the development of significant cell-mediated immunity with activated T cells, macrophages, tissue factor, and fibrin at the site of glomerular injury, suggesting that this glomerular disease is most likely a manifestation of T cell-directed cognate immune injury.

Citing Articles

Crescentic Glomerulonephritis: Pathogenesis and Therapeutic Potential of Human Amniotic Stem Cells.

Al Mushafi A, Ooi J, Odobasic D Front Physiol. 2021; 12:724186.

PMID: 34721059 PMC: 8554237. DOI: 10.3389/fphys.2021.724186.


Emerging Cellular Therapies for Anti-myeloperoxidase Vasculitis and Other Autoimmune Diseases.

Odobasic D, Holdsworth S Front Immunol. 2021; 12:642127.

PMID: 34394071 PMC: 8358391. DOI: 10.3389/fimmu.2021.642127.


Conventional Type 1 Dendritic Cells (cDC1) in Human Kidney Diseases: Clinico-Pathological Correlations.

Chen T, Cao Q, Wang R, Zheng G, Azmi F, Wang J Front Immunol. 2021; 12:635212.

PMID: 34054804 PMC: 8149958. DOI: 10.3389/fimmu.2021.635212.


Co-inhibitory Receptor Signaling in T-Cell-Mediated Autoimmune Glomerulonephritis.

Nagai K Front Med (Lausanne). 2020; 7:584382.

PMID: 33251233 PMC: 7672203. DOI: 10.3389/fmed.2020.584382.


Animal Models of ANCA Associated Vasculitis.

Shochet L, Holdsworth S, Kitching A Front Immunol. 2020; 11:525.

PMID: 32373109 PMC: 7179669. DOI: 10.3389/fimmu.2020.00525.